We can offer a discount on bulk orders. Please contact our sales team for further inquiry.
Product Infomation
Product Name CD19 car circRNA-LNP, CD19-targeting circular RNA chimeric antigen receptor lipid nanoparticles
Catalog Number R-CD19 car circRNA-LNP
Appearance Milky white or translucent nanoparticle suspension
Molecular Formula N/A
Solubility /
Storage -20°C, protected from light
Purity 95%+
Shelf Life 1 year
Shipping Condition low temperature transport
Application gene therapy research
Specification 100mg:Inquiry
200mg:Inquiry
500mg:Inquiry
Description CD19 car circRNA-LNP is a revolutionary gene-immune treatment complex system that innovatively combines three cutting-edge technologies: chimeric antigen receptor (CAR) targeting CD19, circular RNA (circRNA) gene expression platform and lipid nanoparticle (LNP) delivery system. This product aims to overcome the key limitations of traditional disease-poison vector CAR-T therapies, such as long preparation cycles, high costs, potential risks of insertional mutations and complex in vitro manufacturing processes, and provide a safer, faster and scalable treatment option for B cell malignant tumors.
Online Inquiry
For Research or Industrial Raw Materials, Not For Personal Medical Use!
Copyright © MATEXCEL. All Rights Reserved.
0
Inquiry Basket